Revance Therapeutic (RVNC) PT Raised to $35 at Needham & Company

September 8, 2022 11:19 AM EDT Send to a Friend

Needham & Company analyst Serge Belanger ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Revance Therapeutic (RVNC) PT Raised to $35 at Needham & Company

Member Login

Free News Feed